The agency that oversees the drug approval process in Europe is moving to Amsterdam, gene editing gets its first human trial, and a tiny sensor detects even a few oxytocin molecules in blood.

Black parents are less likely than white parents to report concerns about autism features in their children, human brain organoids in rodent bodies raise ethical concerns, and science graduate programs in the United States have few American students.

Giving the autism community a voice in research means engaging in meaningful dialogue, not just making token gestures.

A gene called TRIO may be a hotbed for autism mutations, an international collaboration focuses on the whole brain and one behavior, and Autism Speaks cuts grant spending.

Scores of parents abandon mainstream autism treatments to pursue Son-Rise, an intense, expensive — and unproven — behavioral therapy.

Two studies back the link between autism and maternal inflammation, other work weakens worry about antidepressant use in pregnancy, and a harassment scandal rocks a university’s cognitive science department.

A monkey study suggests facial recognition is not innate, a puzzle piece symbol carries negative connotations, and scientists are using a federal law to snoop on colleagues.

Every state in the country should require that all children be vaccinated before attending school.

People with autism aren’t easily surprised, the social camouflage some girls and women with autism use may preclude diagnosis, and autism-related genes are rooted deep in human ancestry.

Researchers in Oregon edit human embryos, prenatal antidepressants may play a role in autism risk, and gut microbiota are associated with early cognition.